Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage genetic medicine biotechnology company, employs a dedicated workforce of approximately 150 to 200 full-time professionals. Its personnel primarily consist of research scientists, molecular biologists, clinical operations specialists, and laboratory technicians dedicated to advancing stereopure oligonucleotide therapeutics for genetically defined diseases.